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Abstract The Almirall European Headache Awards
(AEHA) were organized in conjunction with the European
Headache Federation. The awards were held in 2009, aiming
to share clinical experience and best practice in headache-
related disease management. 56 unusual and challenging
cases of headache from 5 European countries (Belgium,
France, Italy, Portugal and Spain) were judged by a Scientific
Committee including expert representatives from partici-
pating countries, acting as reviewers. Three cases were
selected from each country. The 15 resulting cases were
presented to the Scientific Committee in Madrid, Spain in
November 2009 and awards were given to the top 5 pre-
sentations. This article presents details of these cases,
including the award winning entries. They have been cate-
gorized into four main groups: (a) headaches in rare syn-
dromes; (b) secondary headaches to infectious/autoimmune
causes or post-trauma/mass occupation; (c) headache in
unresolved cases; and (d) other relevant cases. First prize was
awarded to a case involving a 55-year-old male with familial
thrombocytopenia and a unilateral neuralgiform headache
secondary to trigeminal vascular contact, and which was
successfully treated with carbamazepine. Conclusions from
the meeting include: rare syndromes do occur and require
appropriate treatment to improve outcomes; concomitant
diseases may impair adequate diagnosis and should be
investigated; physicians should be cautious and treat possi-
ble serious underlying disease, whilst accurately clarifying
the correct diagnosis; neurological examination and com-
plementary tests may be required; consideration should be
given to possible rare medication events; and some cases
may remain without a clear cause or diagnosis and symptoms
should be treated whilst investigations continue.
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Introduction
The Almirall European Headache Awards (AEHA) were
organized in 2009 with the goal of sharing clinical experi-
ences and improving best practices in headache-related
disease management [1]. It was hoped that this could be
achieved by
• providing a visible incentive for healthcare profession-
als working in the field to document and share
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information regarding the diagnosis and treatment of
rare/unusual cases involving patients with headache-
and/or migraine-related disorders;
• ensuring that such information is made readily available;
• recognizing the work of headache specialists/neurolo-
gists so as to encourage future research and commu-
nication of medical best practices regarding rare and
unusual cases of headache/migraine.
The scheme was initiated and sponsored by Almirall and
supported by the European Headache Federation (EHF),
and for the first award there were five participating Euro-
pean countries: Belgium, France, Italy, Portugal and Spain.
Given the well-recognized need to promote and support on-
going training and communication in the field of headache
differential diagnosis [2], it was decided that the awards for
the AEHA would be in the form of educational grants/
scholarships in this clinical setting.
The Scientific Committee responsible for judging and
presenting the awards included the president of the EHF and
representatives from each of the five participating countries.
Procedures and awards
Details for case submission were distributed across par-
ticipating countries by the EHF via a newsletter and by
Almirall during early 2009 and included the following
instructions:
• The report must be of a maximum of 500 words (word
document format, with Times Roman size 12 font and
single-line spacing).
• Each case should be structured: medical history,
physical examination, complementary tests, diagnosis,
treatment and evolution, and a brief discussion.
• The report should be clear and comprehensive and no
reference to the personal identity of patients and
hospitals was allowed.
• Commercial brands must not be mentioned.
• A maximum of five references was allowed, indicated
in the text and listed at the end of the report in the order
of appearance.
The authors for the top 3 cases from each of the five
participating countries were invited to present their work
to the Scientific Committee in Madrid in November
2009. Presentations were performed in PowerPoint for-
mat, for a maximum duration of 15 min, and audiovisual
material was permitted. The International Scientific
Committee assessed the presentations according to the
following parameters: content and presentation skills,
overall relevance, originality, complexity, and educational
impact of the clinical case. Five award winners were
selected.
A total of 56 cases were received by the Scientific
Committee. The 15 cases selected for presentation were
divided depending on their characteristics into: (a) head-
aches in rare syndromes; (b) secondary headaches; (c)
headache in unresolved diagnosis cases; and (d) other rel-
evant cases (Table 1). The award winners are listed in
Table 2.
Case summaries
Headaches in rare syndromes
Two cases of red ear syndrome were presented at the
meeting. Red ear syndrome is a rare condition, character-
ized by attacks of unilateral pain, discomfort or burning
sensation in the ear, as well as autonomic features
including erythema in the ipsilateral ear [3]. The first case
was presented by S. Shalchian of Lie`ge. This involved a
35-year-old male with a 15-year history of paroxysmal
episodes of reddening and burning sensation in his ears.
The symptoms were triggered by fatigue, alcohol intake,
physical contact with the ears or by exposure to tempera-
ture extremes. The symptoms lasted from 30 min to 1 h
and were followed by a dull burning sensation. The patient
had previously been treated with tramadol and amitripty-
line, and retroauricular vascular ligature, without any sig-
nificant improvement. On physical examination, there were
no abnormal neurological findings. A sublingual nitro-
glycerin provocation test was performed and both ears
became hyperaemic. Three further treatments were tried
Table 1 Characteristics of the
15 cases selected for
presentation to the international
Scientific Committee in Madrid,
Spain in November 2009
Group Characteristics Sub-groups Number of
cases
A Headaches in rare syndromes N/A 6
B Secondary headaches B1: to infectious/autoimmune causes 3
B2: post-trauma/mass occupation 2
C Headache in unresolved
diagnosis cases
N/A 3
D Other relevant cases A rare migraine presentation 1
A migraine preventative treatment adverse event 1
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without success: nerve infiltration with betamethasone and
lidocaine, verapamil, and methysergide. The patient is
currently being treated with indomethacin and his condi-
tion has improved slightly. Lance [3, 4] suggested that red
ear might be associated with upper cervical disorders,
atypical trigeminal and glossopharyngeal neuralgia, tem-
poromandibular joint dysfunction and local axon reflexes.
Other cases have also been reported in association with
primary headaches, including trigeminal autonomic ceph-
alalgia [5]. Due to the various possible causes of this
syndrome, there is no single treatment of choice and many
patients remain treatment resistant. In the case of this
patient, the nitroglycerin test induced a spontaneous attack
and the authors postulated that the symptoms were likely
due to primary trigeminal autonomic cephalalgia.
The second case of red ear syndrome was a 59-year-old
woman with a 10-month history of paroxysmal, near-daily
pain in bilateral auricles, accompanied by erythema, flush-
ing and extreme warmth of both ears (C. Dallochio, Vog-
hera). The pain attacks were spontaneous or less frequently
precipitated by physical activity, and lasted from 30 min to
2 h. Treatment with non-steroidal anti-inflammatory drugs
(NSAIDs) was ineffective; however, gabapentin 300 mg 3
times daily reduced the attack frequency. Physical exami-
nation revealed that all tendon reflexes increased and that
the neck was short and squat with a moderate reduced
mobility of the cervical spine. Magnetic resonance imaging
(MRI) of the brain and cervical spine demonstrated herni-
ation of the cerebellum-tonsils and the medulla oblongata.
The patient underwent a posterior craniovertebral decom-
pression procedure with realignment of the spine. Two
weeks following surgery, symptoms resolved and the
patient stopped taking gabapentin. She has had no recur-
rences for several months. A similar case has been reported
in the literature in which a dental plate was curative in a
patient with temporomandibular joint dysfunction [6].
The third case presented in this category, which was
awarded third place overall, involved a 13-year-old girl
who came to the outpatient clinic with a history of recur-
rent and severe headaches that began when she was 9-year
old (A. Poisson, Lyon). There was a family history of
migraine without aura and personal medical records
included the appearance of a vertical nystagmus at the age
of 2 years. The patient also suffered from recurrent head-
aches which began with retro-orbital and temporal pain,
followed by abdominal pain, vomiting, paraesthesia of the
upper limbs, vertigo and ataxia. A diagnosis of basilar
migraine was made at the age of 9 years. Consultation with
a neurologist and neuro-ophthalmologist confirmed vertical
nystagmus and identified saccadic pursuits and an absence
of vestibulo-ocular reflex inhibition during visual fixation.
Previous acute (paracetamol, ketoprofen, sumatriptan) and
preventative (propranolol and dihydroergotamine) treat-
ments were ineffective. Despite the original diagnosis of
basilar migraine, the absence of aura was an uncommon
feature [7], and poor responses to benchmark migraine
treatments suggested an alternative cause. Genetic screen-
ing of CACNA1A gene showed a typical nucleotide sub-
stitution situated on exon 13, confirming a diagnosis of
episodic ataxia type 2 (EA2). EA2 is characterized by
sporadic episodes of vertigo and ataxia lasting from hours
to days, variably associated with inter-ictal nystagmus [8,
9]. These features were present in the current case.
Administration of topiramate 30 mg/day was successful as
the patient no longer suffered headache and ataxia. EA2 is
associated with variable gene mutations and whilst family
history regarding migraine should be documented, as it was
in this case, it should not delay accurate diagnosis.
A further case of headache in rare syndromes was a 54-
year-old male admitted to the emergency room with
headache and transient visual loss (G. Ruiz-Ares, Madrid).
About 6 months before, episodes of unilateral transient
visual loss had started to occur. He had a history of
untreated dyslipidemia, mitral stenosis and monthly uni-
lateral pulsating headaches. Physical examination revealed
a grade 3 systolic heart murmur which was maximal along
the right sternal border. Neurological examination did not
highlight any deficits. A complete ophthalmological
examination showed a mild inferior altitudinal scotoma in
the visual field of the right eye. Laboratory tests were
Table 2 Winners of the Almirall European Headache Awards (AEHA)
Award Recipient Institution Country Case
1st D. Grimaldi Neurological Sciences Department,
Bologna University
Italy Unilateral short lasting headache attacks with
autonomic signs
2nd S. Batista Neurology Department, University
Hospital of Coimbra
Portugal Migraine-like headache and recurrent coma
3rd A. Poisson Neurology Service, Hospital Croix Rousse, Lyon France Basilar migraine with inter-ictal nystagmus
4th H.-L. Verschelde Headache Clinic, Neurology Department,
Ghent University
Belgium The soldier incapacitated by physical exercise
5th F. Va´zquez-Sa´nchez Neurology Department, Leon Hospital,
Assistential Complex
Spain New-onset stabbing headache
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normal except cholesterol (288 mg/dl). Ocular duplex
ultrasound identified irregular flow in the central retinal
artery with episodes of lack of flow during the longest
diastolic periods. Holter-ECG monitoring confirmed par-
oxysmal atrial fibrillation. Transesophageal echocardiog-
raphy showed moderate mitral stenosis without thrombus
in a normal diameter left atrium. The patient was diagnosed
with a posterior ischemic optic neuropathy (PION). Oral
anticoagulants and atorvastatin were prescribed and the
patient has not experienced any new visual attacks. Al-
motriptan has successfully treated the episodes of head-
ache. However, the visual field defect has not changed. The
possibility of PION should be considered in the differential
diagnosis of retrobulbar neuropathies.
A 47-year-old male experienced pain within a well-
defined elliptical area (8 9 6 cm) located in the right pari-
eto-occipital region (A. Guerrero, Valladolid). The pain had
persisted for 8 months and did not present with any asso-
ciated symptoms. The patient had 12–14 attacks per day,
usually stabbing/severe pain for 10 s and in the same area. In
addition, he experienced 6–8 paroxysms per day with
throbbing pain radiating to the ipsilateral eye, presenting
with lacrimation. Neurological examination did not reveal
any deficits. The symptomatic area was tender, but there was
no sensitivity to palpation of other pericranial structures.
The patient was diagnosed with nummular headache (NH)
and epicrania fugax (EF). Gabapentin was initially pre-
scribed, but this was ineffective. High doses (up to 200 mg
daily) of carbamazepine improved the pain and paroxysms.
NH was first described in 2002 [10], and is defined as a
primary, focal, continuous pain, restricted to a small well-
defined round or elliptical-shaped area of the head surface
[11]. EF is a novel syndrome recently proposed in a group of
patients presenting with ultra brief shooting pain paroxysms,
starting in posterior cephalic regions and rapidly spreading
to the ipsilateral eye. Focal stemming area presents a well-
shaped inter-ictal pain together with in situ exacerbations,
which may be representative of a link between NH and EF.
Evidence suggests that NH is a non-generalized disorder
with a peripheral source [12].
The case study which was voted first in the AEHA
awards involved a 55-year-old male with familial throm-
bocytopenia who had experienced severe burning-like pain,
daytime headaches in the right orbital and temporal areas
for 9 years (D. Grimaldi, Bologna). These attacks were
associated with ipsilateral conjunctival injection, ptosis,
lacrimation and rhinorrhea which were spontaneous or
triggered by chewing or touching the face. The episodes
lasted from seconds up to 40 min, and occurred 1–6 times
per day for 1 month per year. Initial treatment was with
gabapentin, but the attacks recently became more frequent.
Pregabalin, verapamil, and methylprednisolone were inef-
fective. MRI demonstrated an aberrant loop of the right
superior cerebellar artery which was compressing the tri-
geminal nerve, but surgery was not considered an option
due to thrombocytopenia. Treatment with indomethacin
and carbamazepine was successfully implemented, and
efficacy was maintained following the withdrawal of the
indomethacin after the first month. The patient was diag-
nosed with Short lasting Unilateral Neuralgiform headache
with Conjunctival injection and Tearing (SUNCT), sec-
ondary to trigeminal vascular contact. Based on these
findings, brain imaging is recommended when trigeminal
neuralgia and SUNCT are both present.
Secondary headache
Headaches secondary to infectious/autoimmune causes
The first case of a patient with headache secondary to
infectious disease discussed at the meeting involved a 56-
year-old insulin-dependent diabetic male who presented at
the emergency department with a slow progressive head-
ache, associated with difficulty swallowing and sleeping
(C. Burcin, Paris). Six months earlier, the patient had
developed frequent headaches. He had previously been
diagnosed with otitis and sinusitis and treated with antibi-
otics and oral prednisone, with short-lasting improvement
before recurrence of symptoms. Prominent bilateral cervi-
cal pain developed, which was increased by the motion of
the neck and decubitus. Dysphonia, dysphagia and mild
dysarthria developed progressively over the next few
weeks. Physical examination revealed mild left ptosis, left
hearing loss, and deviation of the tongue to the right. The
patient showed diffuse hyper-reflexia with flexor plantar
response and his gait was slow but stable. The results of a
lumbar puncture reported 17 leukocytes, 1 erythrocyte and
elevated protein (0.88 g/l). MRI revealed spondylodiscitis
in the cranio-cervical junction and a computerized
tomography (CT) scan showed diastasis of the odontoid.
The patient was diagnosed with pyogenic osteitis. Lesion
biopsies identified multiple types of bacteria; however, IV
(intravenous) antibiotics did not prevent lesion progression.
A neurosurgical procedure was performed with posterior
stabilization and anterior decompression. After minor
complications, the patient stabilized and was sent home.
This case underlies the importance of a complete exami-
nation in the case of posterior headache, particularly if
accompanied by bulbar deficits. Pyogenic osteitis of the
spine often involves the lumbar segment and cervical
involvement is rare [13]. Predisposing factors are advanc-
ing age and compromised immunity, with diabetes being a
frequent co-morbidity [14].
A 26-year-old man being treated for hypothyroidism
attended the emergency department due to a 7-day pro-
gressive bilateral frontal headache, accompanied with
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nausea and vomiting (E. Leroux, Paris). A CT scan was
normal and the patient was sent home with analgesics.
However, he returned to the clinic due to persisting pain
and nausea. He appeared apathetic and spoke in few words,
with occasional distraught gaze. He scored 22/30 in the
Mini Mental State Examination, and clock and simple copy
drawing tests were both abnormal. A lumbar puncture was
performed, and the results showed 340 white cells (99%
lymphocytes), 4 red cells and elevated protein (0.94 g/l).
The patient was hospitalized with suspected viral enceph-
alitis. Thyroid stimulating hormone (TSH) was normal, but
antibodies for thyroxin peroxidase (TPO) and thyroglobu-
lin (TG) were both positive. The patient was diagnosed
with Steroid Responsive Encephalopathy with Auto-
immune Thyroiditis (SREAT) and was treated with IV
prednisolone; the headaches disappeared and cognitive
function improved. One month later, the patient was
headache free, but continued to complain of fatigue. This
case emphasizes the importance of cognitive testing in the
emergency department when facing a patient with head-
ache and unusual behaviour. SREAT is a rare but treatable
form of encephalitis and may initially present with isolated
headache and subtle cognitive deficits. A trial of prednis-
olone is both diagnostic and therapeutic, after other causes
of encephalopathy are excluded.
A third case of headache secondary to infectious/auto-
immune causes involved a 32-year-old woman with a
history of headache ([4 per month), treated with NSAIDs
(F. De Santis, Avezzano). The patient visited a neurologist
due to the onset of a persisting hyperacute frontal tension
headache. Neurological examination showed dysphasia,
agitation and confusion, without neck rigidity. Cerebro-
spinal fluid (CSF) leakage was found, with[10 cells/mm3
and increased protein concentration (73 g/l). There was a
dramatic improvement in behavioural and language dis-
turbances following a lumbar puncture. An electroen-
cephalogram (EEG) demonstrated polymorphic delta
waves on the front–temporal sides. The patient was diag-
nosed with viral encephalitis and received an IV infusion of
mannitol, dexamethasone, and antibiotics. Carbamazepine
200 mg and alprazolam 0.25 mg were also administered.
This case underlines the clinical relevance of a headache
with unusual characteristics accompanied by neurological
focal symptoms. The sudden improvement of symptoms
following lumbar puncture suggested the presence of a
very early onset endocranic hypertension [15, 16], which
previously has been reported in meningoencephalitis and in
encephalitis of specific aetiology [17, 18].
Post-trauma/mass occupation secondary headaches
The fourth AEHA prize was awarded for a presentation of
a case involving a 46-year-old male soldier who
developed a bifrontal stabbing headache and neck pain
1 week after a minor accident (H.-L. Verschelde, Ghent).
The headache was exacerbated by exercise, and was
relieved after lying down. Initially, a diagnosis of post-
traumatic ‘‘cervicogenic headache’’ was proposed, but
treatment was ineffective. CSF hypovolemia was sus-
pected and the patient administered IV caffeine; however,
this was unsuccessful. A lumbar blood patch temporarily
relieved the pain, but a second blood patch was not
effective. Due to the pain after physical exercise, primary
exertional headache was suspected and a partial response
was achieved with indomethacin. The patient was then
treated with propranolol and improved over the course of
weeks. Upon review 2 years following the initial symp-
toms, the patient was pain-free but avoided physical
exertion as it provoked headache. Indeed, 1 year later
there was a recurrence following exercise. Propranolol
was restarted, but it was only partially effective. A few
months later, the patient suffered an orthostatic headache
which was relieved by rest. A brain MRI indicated
meningeal enhancement, suggestive of CSF hypovolemia.
The patient was treated with a cervicodorsal blood patch,
with complete recovery indicating that the leak was likely
located at cervicodorsal level. Intracranial hypovolemia
often presents as an orthostatic headache, which may
become a lingering chronic daily headache. In this case,
headache exacerbations were provoked by physical exer-
cise and therefore mimicked exertional headache,
impairing diagnosis.
A 36-year-old woman with a history of long-term
migraine presented at the clinic with a stabbing headache
(F. Va´zquez-Sa´nchez, Leo´n). The ‘‘jabs’’ were of brief
duration, severe intensity and were located mainly in the
parieto-temporal areas. They appeared several times per
day, with no associated triggers or other symptoms. A
MRI scan showed a mass located in the pituitary, dis-
placing the optic chiasm and compressing the posterior
pituitary lobe and both cavernous sinuses. Hormonal tests
demonstrated elevation of growth hormone and somato-
medin C. The patient was diagnosed with stabbing
headache, secondary to acromegaly. Initial treatment with
indomethacin 75 mg was ineffective and this was changed
to topiramate 50 mg which produced a complete recov-
ery. Adult patients who have new-onset stabbing head-
ache should undergo a diagnostic evaluation to exclude
secondary causes [19]. A recent publication reported that
patients with pituitary tumours who suffered headaches
had pain indicative of primary stabbing headache in 27%
of cases [20]. Pharmacological treatment is necessary for
patients who have frequent attacks and indomethacin is
usually the medication of choice. There are no previous
reports describing the use of topiramate for the treatment
of stabbing headache.
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Headache in unresolved diagnosis cases
The case awarded second prize described a 51-year-old
woman who had experienced four episodes of coma pre-
ceded by migraine-like headaches within the last 2 years
(S. Batista, Coimbra). Headaches started without apparent
triggers, presenting with a migraine-like throbbing pain
with nausea, photophobia, aphasia, ataxia and fluctuating
levels of attention and alertness; followed by a generalized
tonic-clonic seizure. The patient entered a comatose state,
responding only to painful stimuli. The fourth episode was
the most severe, with deep coma requiring orotracheal
intubation. The attacks typically lasted 5 days with pro-
gressive recuperation before returning to baseline func-
tioning. However, after the last episode, a significant
cognitive impairment persisted. A single photon emission
computed tomography (SPECT) scan demonstrated that
cerebral perfusion was slightly decreased and it had an
irregular distribution. During comas, EEG showed contin-
uous generalized slow wave activity and intermittent
rhythmic theta activity. In all critical episodes, there were
high CSF proteins (150–160 g/l) without pleocytosis.
Diagnosis was unclear but autoimmune neuronal channel-
opathy was suspected. Acute attacks were treated with
dexamethasone 5 mg IV, phenytoin 250 mg IV, and val-
proic acid 300 mg IV. The patient was also regularly
treated with valproic acid 500 mg, acetazolamide 250 mg,
and phenytoin 300 mg. After the fourth episode, IV
immunoglobulin G 25 g/month was initiated. Since this
treatment was initiated the patient has had only one minor
attack which did not progress to the generalized seizure and
a comatose state. Structural lesions, infectious, metabolic
and toxic disorders were excluded and the patient was
diagnosed with neuronal channelopathy [21]. The presence
of CSF albumin-cytologic dissociation suggests autoim-
mune neuronal channelopathy [22, 23], and provides a
rational for immunomodulator treatment.
A second case of unresolved, undiagnosed headache
involved a 60-year-old woman who had suffered from
episodic migraine with aura since puberty and a more-
recent 2-year history of left episodic orbitofrontal headache
(C. Sa´nchez Bueno, Portima˜o). The headaches persisted for
more than 4 h and invariably were severe and presented
with vomiting and periorbital, anterior neck and upper
trunk ecchymosis. They improved following administration
of analgesics. Blood tests were normal. The patient was
diagnosed with episodic migraine with aura/tension type
headaches with associated ecchymosis. Preventative treat-
ment with topiramate 100 mg was stopped due to drowsi-
ness, but the attacks restarted, so administration was
resumed. Acute episodes were treated with zolmitriptan
5 mg and almotriptan 12.5 mg. The relationship between
migraine and other trigeminal-mediated headaches has
been described in the literature without a conclusive
explanation [24–26]. The improvement of the ecchymosis
depends on headache control as there is no specific treat-
ment for this condition. There are few cases published and
the pathophysiology is unknown.
Other relevant cases: a rare migraine presentation/
a migraine preventive treatment adverse event
A 41-year-old woman was diagnosed with hemiplegic
migraine at the age of 13 (E. Verhellen, Bruges). Attacks
usually started with visual disturbances, followed by
numbness and a hemiparesis, lasting for 30 min. The
patient developed a throbbing headache with photophobia,
phonophobia and vomiting, which usually lasted for peri-
ods of up to 2 days. She suffered several episodes per
month and was treated with sotalol and topiramate. The
patient presented at the emergency room with fever, axial
rigidity, and stupor following one of her attacks. An EEG
showed generalized slowing with paroxysmal delta activ-
ity, higher in the right hemisphere, but without signs of
epileptic activity. A SPECT scan showed diminished per-
fusion in the left parietal and right frontal lobe and IV
valproate and dexamethasone were administered. Due to
suspected meningitis, antibiotics and acyclovir were also
prescribed. A lumbar puncture was normal and no evidence
of meningitis was found. The patient was diagnosed with
hemiplegic migraine with fever and stupor. After 1 week,
the patient completely recovered. Cases with hyperpyrexia
and impaired consciousness have previously been descri-
bed in the literature, which may simulate meningitis,
resulting in inaccurate diagnoses [27–29].
The final case presented was a 22-year-old woman
attending the emergency department due to bilateral
‘‘blurred’’ vision, which had developed over the last 12 h
but it was not associated with pain (F. Palavra, Coimbra).
She had taken topiramate 100 mg/day for the previous
2 days. The patient had a history of frequent episodes of
intense and pulsating headaches since adolescence. These
episodes lasted more than 24 h, at a frequency of 4 per
month and were affecting her daily activities. Other than
pain, she also reported nausea, vomiting, photo- and
phonophobia and a loss of pain relief with her usual
medication (oral nimesulide 100 mg and lysine acetylsa-
licylate 1,000 mg). Based on the clinical presentation, a
diagnosis of migraine without aura was made and the
patient began regular prophylaxis with topiramate (the
dose increased by 25 mg/week, until a target dose of
100 mg/day was reached) and zolmitriptan was adminis-
tered for acute relief depending on the severity of
symptoms. However, the patient also had glaucoma, with
raised intra-ocular pressure and some morphological
abnormalities in the iris. Topiramate-induced acute
212 J Headache Pain (2010) 11:207–214
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myopia was diagnosed and this drug was immediately
discontinued. The patient was treated with timolol 0.5%
eye drops for 2 weeks and 4 days later her visual acuity
was improved and this improvement has been maintained
ever since. Acute topiramate-induced myopia is a rare
idiosyncratic reaction [30], usually presenting with sudden
bilateral blurred vision [31]. Topiramate is a sulphamate-
substituted monosaccharide which induces ciliary body
oedema and increases aqueous humour production; these
effects contribute to forward movement of the iris. A
sudden closure of the anterior chamber angle can pre-
cipitate acute glaucoma, which is a potentially serious
condition, although, as in this case, it does resolve with
drug discontinuation [32, 33].
General comments and conclusions
Headache represents one of the most common reasons for
a patient to consult their general practitioner (GP). Whilst
the majority of cases are straightforward and easily
resolved, this is not always the case. Indeed, the recent
Headache Management Pattern (HMP) survey highlighted
areas of weakness in the diagnosis and treatment of
patients with headache at the primary care level, partic-
ularly with regard to chronic migraine, medication abuse
headache and tension-type headache [2]. The authors
concluded by emphasizing the need for both continuing
medical education and also improved referral to specialist
care. The goal of the AEHA is to encourage physicians
to share their experiences of unusual/rare cases of
headache so as to increase the awareness of the medical
community.
The AEHA presented 15 varied and interesting head-
ache-related challenging case reports from five European
countries. In this regard, the AEHA can be considered a
success and has provided useful information for physicians
working in this field. Specific conclusions are difficult
given the diversity and complexity of the cases presented.
However, general conclusions which may improve diag-
nosis and care of patients include:
• Rare syndromes do occur and require appropriate
treatment to enhance quality of life for the patient.
• Concomitant diseases may impair adequate diagnosis
of headache and should be considered.
• Full neurological examinations and complementary
tests may be required.
• Infections, trauma, cancer or autoimmune disease may
be behind chronic or acute headaches and complemen-
tary tests offer invaluable help.
• Low frequency symptoms in some headaches may
cause misdiagnoses.
• Physicians should be cautious and treat possible serious
underlying disease, whilst accurately clarifying the
correct diagnosis.
• A further consideration is the possibility of a rare
medication-related event.
• Some cases may remain without a clear cause or
diagnosis and symptoms should be treated whilst
continuing to assess the true origin.
Finally, all those involved with the AEHA considered
the programme a success, providing an interesting forum
for advancing our knowledge about diagnosis, treatment
and safety issues relating to rare and unusual cases of
headache/migraine.
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